Financials SenesTech, Inc.

Equities

SNES

US81720R5054

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:01 2024-05-17 pm EDT 5-day change 1st Jan Change
0.69 USD +1.10% Intraday chart for SenesTech, Inc. +1.69% -45.67%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 15.56 7.761 11.95 2.108 6.082 3.55 - -
Enterprise Value (EV) 1 15.56 7.761 11.95 2.108 6.082 3.55 3.55 3.55
P/E ratio -1.43 x -0.62 x -1.32 x -0.2 x -0.11 x -0.63 x -1.53 x -1.68 x
Yield - - - - - - - -
Capitalization / Revenue 109 x 27.5 x 19.9 x - 5.1 x 1.59 x 0.79 x 0.44 x
EV / Revenue 109 x 27.5 x 19.9 x - 5.1 x 1.59 x 0.79 x 0.44 x
EV / EBITDA - -1.13 x -1.52 x - -0.88 x -0.67 x -0.76 x -1.02 x
EV / FCF - -1.07 x - - - -0.52 x -0.63 x -0.87 x
FCF Yield - -93.1% - - - -193% -158% -115%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 5.89 18.7 50.9 56.8 4,789 5,145 - -
Reference price 2 2,640 414.0 234.9 37.08 1.270 0.6900 0.6900 0.6900
Announcement Date 3/16/20 3/25/21 3/29/22 3/16/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 0.143 0.282 0.6 - 1.193 2.239 4.508 8.114
EBITDA 1 - -6.881 -7.841 - -6.922 -5.314 -4.655 -3.491
EBIT 1 -10.29 -7.933 -8.934 - -7.732 -6.192 -5.885 -4.778
Operating Margin -7,193.71% -2,813.12% -1,489% - -648.11% -276.55% -130.55% -58.89%
Earnings before Tax (EBT) 1 -10.02 -7.937 -8.268 - -7.71 -6.621 -6.852 -6.167
Net income 1 -10.03 -8.373 -8.268 -9.695 -7.71 -6.621 -6.852 -6.167
Net margin -7,013.29% -2,969.15% -1,378% - -646.27% -295.71% -152% -76%
EPS 2 -1,846 -667.2 -177.6 -186.0 -11.51 -1.100 -0.4500 -0.4100
Free Cash Flow 1 - -7.222 - - - -6.835 -5.612 -4.082
FCF margin - -2,560.99% - - - -305.27% -124.49% -50.31%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/16/20 3/25/21 3/29/22 3/16/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 0.169 0.195 0.277 0.25 0.233 0.305 0.36 0.295 0.415 0.485 0.582 0.757
EBITDA 1 -2.165 -2.043 -2.277 -2.501 -1.843 -1.678 -1.746 -1.617 -1.721 -1.358 -1.203 -1.032
EBIT 1 -2.493 -2.333 -2.572 -2.619 -2.045 -2 -1.951 -1.736 -1.843 -1.604 -1.466 -1.279
Operating Margin -1,475.15% -1,196.41% -928.52% -1,047.6% -877.68% -655.74% -541.94% -588.47% -444.1% -330.72% -251.89% -168.96%
Earnings before Tax (EBT) 1 -2.494 -2.332 -2.569 -2.646 -2.037 -1.993 -1.947 -1.733 -1.832 -1.672 -1.638 -1.48
Net income 1 -2.494 -2.332 -2.569 -2.646 -2.037 -1.993 -1.947 -1.733 -1.832 -1.672 -1.638 -1.48
Net margin -1,475.74% -1,195.9% -927.44% -1,058.4% -874.25% -653.44% -540.83% -587.46% -441.45% -344.74% -281.44% -195.51%
EPS 2 -50.40 -45.60 -50.40 -52.80 -15.84 -8.400 -5.640 -9.540 -0.3600 -0.3200 -0.3200 -0.1000
Dividend per Share - - - - - - - - - - - -
Announcement Date 3/29/22 5/12/22 8/11/22 11/14/22 5/11/23 8/10/23 11/9/23 2/21/24 5/9/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - -7.22 - - - -6.84 -5.61 -4.08
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - 0.11 - - - - - -
Capex / Sales - 40.43% - - - - - -
Announcement Date 3/16/20 3/25/21 3/29/22 3/16/23 2/21/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.69 USD
Average target price
3.5 USD
Spread / Average Target
+407.25%
Consensus
  1. Stock Market
  2. Equities
  3. SNES Stock
  4. Financials SenesTech, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW